It has been reported that hesperetin could be a potential therapeutic compound for periodontitis since it suppressed RANKL-induced osteoclastogenesis, osteoclastic bone resorption, and the activation of NF-κB and MAPK signaling in RAW 264.7 cells. The gene discussed is NFKB1; the disease is periodontitis.